Bayern Kapital

Activity from announced rounds

All recorded activity

Bayern Kapital is an investment manager identified in its own QuantumDiamonds announcement and by counsel in HyImpulse’s financing.

Recorded funding activity

QuantumDiamonds develops semiconductor testing technology for finding chip defects. HyImpulse builds hybrid-propulsion rockets for suborbital research and small-satellite launches. The recorded activity also includes Arcos’ physical-security operations software and monitoring services. The manager’s history remains distinct from separately named Bayern funds.

Sources
Rounds participated in
17
Confirmed lead rounds
0
8 roles undisclosed
New companies
14
First participation on record · 3 follow-on
Funding in participating rounds
$516.3M
8 disclosed · full round size, not this investor’s share

By stage

Seed5
Series A5
Pre-seed3
Series B2
Growth1
1 more
Undisclosed1

By primary sector

Climate tech5
Biotech3
Cybersecurity3
Space tech2
Agritech1
3 more
Enterprise software1
Hardware1
Healthtech1

By country

Germany17

Rounds

17 in all activity
Elevatry

Elevatry provides AI assistants for strategic procurement teams.

€3MPre-seed
Participant
Finches

Bavarian company providing early warnings about agricultural supply risks.

€2MPre-seed
Participant
Arcos

Physical-security operations software and alarm-monitoring services that bring sensor, camera and alarm signals into one system for assessing incidents and coordinating response.

Role not disclosed
HyImpulse

A launch-services company developing hybrid-propulsion rockets for suborbital research flights and small-satellite launches to orbit.

>€50MSeries A extension
Participant
QuantumDiamonds

Develops technology to test and find defects in semiconductor products

€15MUndisclosed
Role not disclosed
Proxima Fusion

Develops commercial fusion power plants based on stellarator concept

€411MGrowth
Role not disclosed
NanoStruct

Develops nanostructured sensor chips for rapid pathogen detection in food

Role not disclosed
mbiomics

mbiomics develops live bacterial therapeutics using precisely designed microbial communities.

€12MSeries A third close
Participant
Neuramancer AI Solutions

Develops AI technology to detect deepfakes and synthetic media manipulation for fraud prevention

€1.7MPre-Seed
Role not disclosed
Noxon

Develops non-invasive Muscle-Computer Interface for neuromuscular disorders

Role not disclosed
Secfix

Provides platform to automate security compliance and certification management

$12MSeries A
Role not disclosed
Twogee Biotech

Develops customised enzyme solutions for converting biomass into sustainable raw materials

Role not disclosed
Proxima Fusion

Develops commercial fusion power plants based on stellarator concept

€130MSeries A
Participant
OroraTech

OroraTech provides satellite-based thermal intelligence for wildfire detection, risk assessment and monitoring.

UndisclosedSeries B extended to €37m cumulative total
Participant
Marvel Fusion

Marvel Fusion develops laser-driven fusion energy systems.

€50MSeries B extension
Participant
Proxima Fusion

Develops commercial fusion power plants based on stellarator concept

€20MSeed
Participant
mbiomics

mbiomics develops live bacterial therapeutics using precisely designed microbial communities.

€13MSeries A first close
Participant